Your browser doesn't support javascript.
loading
Adult acute megakaryoblastic leukemia: rare association with cytopenias of undetermined significance and p210 and p190 BCR-ABL transcripts.
Dima, Delia; Oprita, Liana; Rosu, Ana-Maria; Trifa, Adrian; Selicean, Cristina; Moisoiu, Vlad; Frinc, Ioana; Zdrenghea, Mihnea; Tomuleasa, Ciprian.
Afiliação
  • Dima D; Department of Hematology, Ion Chiricuta Oncology Institute.
  • Oprita L; Department of Dentistry.
  • Rosu AM; Research Center for Functional Genomics and Translational Medicine.
  • Trifa A; Department of Genetics.
  • Selicean C; Department of Hematology, Ion Chiricuta Oncology Institute.
  • Moisoiu V; Research Center for Functional Genomics and Translational Medicine.
  • Frinc I; Department of Hematology, Ion Chiricuta Oncology Institute.
  • Zdrenghea M; Department of Hematology, Ion Chiricuta Oncology Institute.
  • Tomuleasa C; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Onco Targets Ther ; 10: 5047-5051, 2017.
Article em En | MEDLINE | ID: mdl-29089774
Acute megakaryocytic leukemia (M7-AML) is a rare form of acute myeloid leukemia (AML), which is associated with poor prognosis. The case presented in the current report is a statement for the difficult diagnosis and clinical management of M7-AML in the context of a previous hematologic disorder of undetermined significance and associated genetic abnormalities. Probably, following the complete hematologic remission and further with induction chemotherapy plus tyrosine kinase inhibitor therapy, the clinical management of this case will be followed by a allogeneic bone marrow transplantation, the only proven therapy to improve overall survival.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2017 Tipo de documento: Article